<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Bronchiectasis in children: Clinical manifestations and evaluation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Bronchiectasis in children: Clinical manifestations and evaluation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Bronchiectasis in children: Clinical manifestations and evaluation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vikas Goyal, MBBS, DCH, FRACP, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anne B Chang, MBBS, FRACP, PhD, FAPSR, FAHMS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            George B Mallory, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 17, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Worldwide, the prevalence of bronchiectasis unrelated to cystic fibrosis exceeds that of cystic fibrosis-associated bronchiectasis. Although bronchiectasis remains a major contributor to chronic respiratory morbidity in both affluent [
         <a href="#rid1">
          1,2
         </a>
         ] and less affluent countries [
         <a href="#rid3">
          3,4
         </a>
         ], it remains an underrecognized and neglected disease.
        </p>
        <p>
         Bronchiectasis was previously considered to be irreversible and progressive. However, studies have shown that disease progression in children can be halted and even reversed (as measured by imaging) with optimized clinical management [
         <a href="#rid5">
          5
         </a>
         ]. Thus, awareness of disease leading to early recognition, evaluation, and prompt treatment is particularly important in children to reduce disease progression and the associated health and economic consequences [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         The clinical presentation and evaluation of a child with bronchiectasis due to causes other than cystic fibrosis is discussed below. The causes and treatment of bronchiectasis in children without cystic fibrosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6358.html" rel="external">
          "Bronchiectasis in children: Pathophysiology and causes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6355.html" rel="external">
          "Bronchiectasis in children without cystic fibrosis: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2971389419">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiectasis in children is defined as the presence of abnormal bronchial dilatation on chest computed tomography (CT) scans, in combination with a clinical syndrome of recurrent or persistent wet/productive cough, airway infection, and/or inflammation [
         <a href="#rid5">
          5,8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2165197455">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are few reliable prevalence estimates for bronchiectasis in children. Extrapolation of published data suggests highly variable incidence, ranging from 0.2 to 735 per 100,000 children annually [
         <a href="#rid9">
          9
         </a>
         ]. The prevalence is particularly high among children in indigenous populations in Australia, New Zealand, and Alaska (1 in every 63 to 68 children [
         <a href="#rid10">
          10
         </a>
         ]) and low-income settings [
         <a href="#rid11">
          11
         </a>
         ]. The disease is increasingly recognized in the general population, especially in major cities.
        </p>
        <p>
         The underlying cause of the bronchiectasis also varies substantially among populations. As examples, infectious causes are more common in certain low-resource or indigenous populations, while immunodeficiencies and other genetic causes are more common in populations with consanguinity or founder mutations. (See
         <a class="medical medical_review" href="/z/d/html/6358.html" rel="external">
          "Bronchiectasis in children: Pathophysiology and causes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children and youth with bronchiectasis can present with a wide variety of symptoms and signs  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ) because it is the end result of a variety of illnesses ranging from congenital causes to postinfectious and primary immunodeficiencies. The clinical manifestations depend primarily on disease severity and whether an underlying disease is present. For example, children with underlying disease risk factors (eg, primary immunodeficiency) or previous protracted bacterial bronchitis (PBB) may present with relatively mild symptoms during routine clinical surveillance. By contrast, children with limited access to medical care or with severe underlying disease may present with more severe symptoms including hemoptysis [
         <a href="#rid9">
          9,12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H322713153">
         <span class="h2">
          Respiratory symptoms and signs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiectasis is associated with a variety of nonspecific symptoms and signs [
         <a href="#rid13">
          13
         </a>
         ]. These are more likely present in those with more severe bronchiectasis (defined radiographically) [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Respiratory symptoms of bronchiectasis include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic wet/productive cough
         </strong>
         – Chronic cough that sounds wet and/or is productive of mucus or phlegm is the most common symptom of bronchiectasis. The cough is typically chronic but may be intermittent post-treatment (unlike that in adults, in which the bronchiectasis-related cough typically persists) [
         <a href="#rid15">
          15
         </a>
         ]. The character and frequency/intensity of the cough reflect its severity (more likely continuously present if bronchiectasis is severe) and state (stable state versus exacerbation) [
         <a href="#rid16">
          16
         </a>
         ]. When productive cough is present, the sputum is usually purulent (prior to treatment) but may be nonpurulent, particularly in children with primary ciliary dyskinesia when in a stable state (ie, not in an exacerbation).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If antibiotics are used in the initial treatment of chronic wet cough, failure of the wet/productive cough to respond to four weeks of antibiotics predicts presence of bronchiectasis (adjusted odds ratio 20.9, 95% CI 5.4-81.8) [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recurrent infections
         </strong>
         – Recurrent pneumonia is both a risk factor [
         <a href="#rid8">
          8,18
         </a>
         ] and presenting symptom [
         <a href="#rid19">
          19
         </a>
         ] of childhood bronchiectasis. In some cases, bronchiectasis may be first identified after a single severe episode of pneumonia, particularly after particular infections such as adenovirus and mycoplasma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Children may also present with recurrent episodes (&gt;3 per year) of PBB [
         <a href="#rid20">
          20,21
         </a>
         ]. The adjusted odds ratio of having bronchiectasis in those with recurrent PBB is 11.5 (95% CI 2.3-56) [
         <a href="#rid20">
          20
         </a>
         ]. This risk is also higher in at-risk populations such as young indigenous children living in high-income countries. In a study of infants from an indigenous Australian population who were hospitalized for bronchiolitis, 20 percent developed bronchiectasis within 13 months after discharge. The presence of chronic cough at three to four weeks post-hospitalisation was a risk factor for a subsequent diagnosis of bronchiectasis (odds ratio 3, 95% CI 1.1-7) [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dyspnea
         </strong>
         – Children with bronchiectasis may have dyspnea, especially on exertion. Although dyspnea is generally rare in cohorts of children in which bronchiectasis was diagnosed early [
         <a href="#rid13">
          13,23
         </a>
         ], it is reported in up to 81 percent of children with bronchiectasis in low- or middle-income countries  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ). Dyspnea may reflect the airway hyperresponsiveness that is common in children with severe bronchiectasis [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemoptysis
         </strong>
         – Hemoptysis is present in 1 to 10 percent of patients and generally reflects more severe bronchiectasis [
         <a href="#rid15">
          15
         </a>
         ]. It may be a presenting symptom, particularly in low- or middle-income countries and if diagnosis is delayed but occasionally in high-income countries [
         <a href="#rid19">
          19
         </a>
         ]. Hemoptysis can be life-threatening; a study from the United States involving 300 children admitted to intensive care with hemoptysis reported that bronchiectasis was the cause in 10 percent and was an independent risk factor for in-hospital mortality [
         <a href="#rid25">
          25
         </a>
         ]. However, 85 percent of the patients with bronchiectasis in this study had cystic fibrosis, so these findings may not reflect the prognosis of patients with other causes of bronchiectasis [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other
         </strong>
         – Other respiratory symptoms that are features of an underlying disease may be found. These include symptoms/signs associated with tracheomalacia (monophonic wheeze, stridor, brassy cough, pectus excavatum) and laryngeal dysfunction or cleft (hoarse voice, stridor).
        </p>
        <p>
        </p>
        <p>
         On physical examination, signs associated with bronchiectasis include  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest crackles
         </strong>
         – Common; reported in up to 89 percent of children in some cohorts [
         <a href="#rid26">
          26
         </a>
         ]. Like other signs and symptoms, the presence of crackles varies with the patient's state (initial diagnosis, stable state post-treatment or exacerbation).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest rhonchi or wheeze
         </strong>
         – Wheeze (which reflects airway obstruction) is sometimes present (10 to 66 percent of cohorts). The presence of wheeze also varies with the patient's state (ie, initial diagnosis, stable state post-treatment, or exacerbation).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest deformity
         </strong>
         (hyperinflation, Harrison sulci, pectus carinatum) – Present in 15 to 29 percent of children.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Digital clubbing
         </strong>
         – Present in 4 to 73 percent of children.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4182753927">
         <span class="h2">
          Systemic symptoms and signs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Systemic markers of bronchiectasis vary widely, reflecting the associated comorbidities and complications as well as the underlying etiology of the child's bronchiectasis.
        </p>
        <p>
         Children with bronchiectasis may have growth failure and other comorbidities that may not directly relate to markers of bronchiectasis severity. These include cardiac dysfunction, pulmonary hypertension, sleep disorders, gastroesophageal reflux, psychosocial challenges, and impaired quality of life [
         <a href="#rid15">
          15,27,28
         </a>
         ]. Comorbidities may also be caused by the medications used for treating the child's bronchiectasis, such as corticosteroids.
        </p>
        <p>
         Other symptoms and signs are related to the underlying cause or risk factor associated with the bronchiectasis  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 2
         </a>
         ). Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Features of extreme prematurity [
         <a href="#rid10">
          10
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital anomalies associated with swallowing dysfunction, such as previous esophageal atresia/tracheoesophageal fistula [
         <a href="#rid29">
          29
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sinusitis with or without situs inversus in those with primary ciliary dyskinesia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndromic features (eg, trisomy 21, in which bronchiectasis is related to dysphagia associated with recurrent small-volume aspiration)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary immunodeficiency, in which symptoms/signs may be specific (eg, ataxia-telangiectasia) or nonspecific (eg, scarred tympanic membrane from previous chronic suppurative otitis media)
        </p>
        <p>
        </p>
        <p>
         Some of the comorbidities that are seen in adults with bronchiectasis, such as rheumatic disease and amyloidosis [
         <a href="#rid7">
          7
         </a>
         ], are much rarer in children. (See
         <a class="medical medical_review" href="/z/d/html/1444.html" rel="external">
          "Clinical manifestations and diagnosis of bronchiectasis in adults", section on 'Etiologies'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          OVERVIEW AND GOALS OF THE EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         For a child with suspected bronchiectasis, goals of the evaluation are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Confirm or exclude the diagnosis of bronchiectasis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Determine its severity and complications
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assess for an underlying cause or risk factor for the bronchiectasis, which informs treatment decisions
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         General assessments to optimize management of the child's bronchiectasis, including bronchiectasis-related education and counselling to enhance adherence to treatment
        </p>
        <p>
        </p>
        <p>
         This information informs the evaluation plan, which includes a panel of tests in all children and more in-depth investigations in selected patients to determine the cause of the bronchiectasis  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 2
         </a>
         ). Defining the cause of the bronchiectasis and/or other factors that may contribute (so-called "treatable traits") also informs the management strategy [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="local">
          'Further evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6355.html" rel="external">
          "Bronchiectasis in children without cystic fibrosis: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H294339373">
         <span class="h1">
          INITIAL EVALUATION OF SUSPECTED BRONCHIECTASIS
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Medical history
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          History of present illness
         </strong>
         – The initial evaluation of a child suspected of having bronchiectasis includes a targeted history focusing on current and past symptoms  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ). Key information includes the characteristics of cough, including its onset and duration, type of cough (wet or dry, time of day), history of response to therapies (if any), and purulence (if sputum can be expectorated).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the cough is wet-sounding, symptoms suggesting one of the more common and treatable causes of bronchiectasis should be specifically explored:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Protracted bacterial bronchitis (PBB) – Recurrent PBB is a relatively common cause of bronchiectasis, especially in certain indigenous populations in Australia, New Zealand, and Alaska and some other populations with limited access to health care [
         <a href="#rid10">
          10
         </a>
         ]. Symptoms of PBB include chronic (&gt;4 weeks) wet or productive cough. Untreated or recurrent PBB can progress to bronchiectasis, which should be suspected in children who have not responded to four weeks of antibiotics or who have &gt;3 episodes per year  (
         <a class="graphic graphic_figure graphicRef115194" href="/z/d/graphic/115194.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6356.html" rel="external">
          "Causes of chronic cough in children", section on 'Protracted bacterial bronchitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Foreign body aspiration – The possibility of foreign body aspiration should be suspected in a child with a history of wheeze, hemoptysis, and sudden onset of cough/choking. (See
         <a class="medical medical_review" href="/z/d/html/6356.html" rel="external">
          "Causes of chronic cough in children", section on 'Inhaled retained airway foreign body'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Related medical history
         </strong>
         – The past medical history should be explored for possible causes or contributing factors, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neonatal history, including prematurity or neonatal distress requiring oxygen (suggests primary ciliary dyskinesia)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Previous severe pneumonia or recurrent pneumonias
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History or risk factors for tuberculosis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HIV status
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiothoracic surgery
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Symptoms or risk factors for dysphagia (eg, neurologic dysfunction)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Features of primary immunodeficiency disease (eg, recurrent infections) as well as risk factors such as consanguinity and family history (see
         <a class="medical medical_review" href="/z/d/html/5949.html" rel="external">
          "Approach to the child with recurrent infections"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Specific questioning on possible inhalation/recurrent small-volume aspiration injuries (eg, lipoid substances [
         <a href="#rid30">
          30
         </a>
         ]) should also be sought in some cultural settings [
         <a href="#rid31">
          31
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other history
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Psychosocial history – Understanding the family's resources and cultural setting informs management strategies. This includes health literacy, which informs the type of education resources used, and/or use of culture-specific educational tools for indigenous people.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Exposure to tobacco smoke and other environmental pollutants – These exposures can contribute to bronchiectasis and should be addressed as part of a treatment plan.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Activity level – The child's activity level should also be assessed for presence of exertional dyspnea. In addition, activity level is relevant to general health as children with bronchiectasis often have suboptimal physical activity levels [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The physical examination includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory signs – The most common sign consistent with bronchiectasis is chronic wet cough, sometimes with wheezing. Patients with more advanced disease may have digital clubbing or chest wall deformity, such as hyperinflation, pectus carinatum, or Harrison sulci (transverse depressions along the sixth and seventh costal cartilages at the site of attachment of the anterior part of the diaphragm)  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ). Identification of scars from previous cardiothoracic surgery may supplement the past medical history.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         General examination – This includes assessment of growth and assessment of other systems (eg, cardiac, skin) with particular attention to issues raised by the medical history. As an example, a child with dysphagia should have a thorough neurologic assessment.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Imaging
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest radiograph
         </strong>
         – A chest radiograph should be performed in all children with chronic wet cough [
         <a href="#rid33">
          33
         </a>
         ]. The primary purpose is to evaluate for clues to the respiratory symptoms, such as foreign body aspiration or pneumonia, which sometimes lead to bronchiectasis. The chest radiograph should not be used to exclude bronchiectasis, as it is insensitive for detecting bronchiectasis [
         <a href="#rid34">
          34
         </a>
         ]. As an example, in a series of 14 patients with bronchiectasis diagnosed by high-resolution computed tomography (HRCT), none had evidence of bronchiectasis on chest radiograph [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When the bronchiectasis is moderate to severe, it may be possible to detect a "tram track" appearance, which consists of parallel lines that reflect the thickened walls of dilated bronchi  (
         <a class="graphic graphic_diagnosticimage graphicRef131111" href="/z/d/graphic/131111.html" rel="external">
          image 1
         </a>
         ). Additionally, if the bronchiectasis is severe, the dilated airway structures may appear as ring-like structures (if the dilated lumen filled with air) or cystic opacities (if the lumen is filled with mucus).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Advanced imaging
         </strong>
         – Advanced imaging (typically multidetector CT [MDCT] with HRCT) should be performed in children with chronic wet cough who have an increased likelihood of underlying bronchiectasis, such as those with a poor response to appropriate antibiotics [
         <a href="#rid17">
          17
         </a>
         ], recurrent PBB [
         <a href="#rid20">
          20
         </a>
         ], or underlying immunodeficiency. HRCT is not indicated for children with first presentation of chronic wet cough and no other signs or risk factors for bronchiectasis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          HRCT
         </strong>
         – HRCT is moderately sensitive and specific for diagnosing the condition. HRCT usually consists of 1 mm sections of the lung every 10 to 15 mm intervals with a high spatial resolution algorithm [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Features of bronchiectasis on HRCT are:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Increased bronchoarterial ratio (BAR) – The pathognomonic feature of bronchiectasis seen on HRCT is an abnormally dilated airway compared with the adjacent artery. The BAR is used as an index for this dilatation; it is defined as the ratio of the inner diameter of an airway to the outer diameter of adjacent artery that is within 5 mm in a nontangential plane  (
         <a class="graphic graphic_diagnosticimage graphicRef131113" href="/z/d/graphic/131113.html" rel="external">
          image 2
         </a>
         ). Although this is the classic method, there is some controversy as to whether the outer diameter of the airway should be used instead [
         <a href="#rid37">
          37
         </a>
         ]. Pediatric guidelines recommends using a BAR of &gt;0.8 to define bronchiectasis (instead of the adult cutoff of &gt;1 or &gt;1.5) [
         <a href="#rid8">
          8,38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Signet ring sign – The airway dilation also results in a characteristic "signet ring" sign  (
         <a class="graphic graphic_diagnosticimage graphicRef131113" href="/z/d/graphic/131113.html" rel="external">
          image 2
         </a>
         ), in which the dilated airway appears as a ring and the adjacent artery resembles a protruding signet or jewel.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Bronchial wall thickening is often present  (
         <a class="graphic graphic_diagnosticimage graphicRef131112" href="/z/d/graphic/131112.html" rel="external">
          image 3
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Other abnormalities associated with bronchiectasis include: a lack of bronchial tapering (from central to periphery), "tram track" lines (depending on the orientation plane), presence of bronchial structures in the lung periphery  (
         <a class="graphic graphic_diagnosticimage graphicRef131114" href="/z/d/graphic/131114.html" rel="external">
          image 4
         </a>
         ), mucus plugging, and mosaic perfusion (reflecting air trapping) [
         <a href="#rid5">
          5
         </a>
         ]. In the acute state, "tree-in-bud" appearance may also be visualised.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         In some cases, the HRCT scan may include a concurrent abnormality related to the underlying disease process associated with bronchiectasis, such as a ground-glass changes reflecting graft-versus-host disease in children with previous transplant  (
         <a class="graphic graphic_diagnosticimage graphicRef131116" href="/z/d/graphic/131116.html" rel="external">
          image 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         False positives of the pathognomonic HRCT abnormality (increased BAR) may occur at high altitude, with asthma, and with reduced pulmonary flow [
         <a href="#rid5">
          5
         </a>
         ]. In children with interstitial lung disease, increased BAR may also be present from pulmonary fibrosis, but patients do not have any symptoms consistent with bronchiectasis. Also, chest CT scans should not be taken to assess the presence of bronchiectasis immediately after an acute infection, as any abnormalities may be reversible.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          MDCT with HRCT
         </strong>
         – Combining MDCT with HRCT has significantly better sensitivity than conventional HRCT in detecting bronchiectasis and should be used when available [
         <a href="#rid39">
          39,40
         </a>
         ]. Accordingly, the European Respiratory Society Clinical Practice Guideline recommends MDCT with HRCT as the primary imaging modality for diagnosing bronchiectasis in children and adolescents [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Magnetic resonance imaging (MRI)
         </strong>
         – MRI has been proposed as an alternative to evaluate small airway disease. However, MRI provides a relatively blurred image (compared with images acquired from HRCT) and can only detect moderate to severe airway abnormalities [
         <a href="#rid41">
          41
         </a>
         ]. MRIs cannot be used to exclude the presence of bronchiectasis. Whether or not MRI can be used for monitoring disease (as opposed to diagnosis) remains to be determined.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Defining severity of radiographic bronchiectasis
         </strong>
         – Historically, bronchiectasis severity was classified as cylindrical, varicose (or fusiform), and cystic (or saccular)  (
         <a class="graphic graphic_figure graphicRef139531" href="/z/d/graphic/139531.html" rel="external">
          figure 2
         </a>
         ), based on the classical appearance of each stage on bronchography [
         <a href="#rid42">
          42
         </a>
         ]. Such appearances are also evident on CT  (
         <a class="graphic graphic_diagnosticimage graphicRef131113" href="/z/d/graphic/131113.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef131114" href="/z/d/graphic/131114.html" rel="external">
          image 4
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef131115" href="/z/d/graphic/131115.html" rel="external">
          image 6
         </a>
         ), although the definition of varicose versus saccular may not be as clear on axial plane compared with coronal or sagittal planes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Various scores have been developed to define severity of bronchiectasis based on HRCT findings, such as the Bhalla [
         <a href="#rid43">
          43
         </a>
         ], Reiff [
         <a href="#rid44">
          44
         </a>
         ], or Webb [
         <a href="#rid45">
          45
         </a>
         ] scores. In each of these, higher scores reflect larger BAR and increasing bronchiectasis severity. These scores correlate with progression from cylindrical to cystic changes. They are used primarily in research on bronchiectasis in patients with or without cystic fibrosis [
         <a href="#rid46">
          46,47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Distribution
         </strong>
         – Bronchiectasis may be focal or generalized  (
         <a class="graphic graphic_table graphicRef71732" href="/z/d/graphic/71732.html" rel="external">
          table 3
         </a>
         ). These characteristics provide clues to the cause but are not reliable and also depend upon the imaging modality; advanced imaging tends to detect more diffuse disease compared with conventional radiographs.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4241036128">
         <span class="h2">
          Spirometry
         </span>
         <span class="headingEndMark">
          —
         </span>
         All children with suspected or confirmed bronchiectasis should be evaluated with spirometry at diagnosis and with serial measures in follow-up [
         <a href="#rid8">
          8,38
         </a>
         ]. The typical spirometric abnormality in bronchiectasis is an obstructive pattern, in which the forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) is low and normal forced vital capacity (FVC) is normal  (
         <a class="graphic graphic_figure graphicRef131119" href="/z/d/graphic/131119.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid14">
          14,18
         </a>
         ]. However, in some children with bronchiectasis, a restrictive pattern may be seen  (
         <a class="graphic graphic_figure graphicRef131120" href="/z/d/graphic/131120.html" rel="external">
          figure 4
         </a>
         ). Whether the restrictive pattern reflects poor lung growth or bronchiectasis per se has not been established.
        </p>
        <p>
         Spirometry has limited sensitivity for defining and/or monitoring the severity of bronchiectasis. In children with mild or cylindrical bronchiectasis, spirometry may be normal and may not correlate with radiographic assessment of severity  (
         <a class="graphic graphic_figure graphicRef131118" href="/z/d/graphic/131118.html" rel="external">
          figure 5
         </a>
         ) [
         <a href="#rid46">
          46,48,49
         </a>
         ]. As an example, in a study involving 67 Turkish children with bronchiectasis, quality-of-life scores were more closely correlated with clinical symptoms (wheezing and dyspnea) than with spirometry indices [
         <a href="#rid28">
          28
         </a>
         ]. The correlation is better for children with moderate to severe bronchiectasis, in whom spirometry is consistently abnormal [
         <a href="#rid14">
          14
         </a>
         ] and generally correlates with severity, as determined by HRCT and prognosis (based on data from adults [
         <a href="#rid7">
          7
         </a>
         ]).
        </p>
        <p>
         Serial spirometry can be used to monitor the functional consequences of bronchiectasis, which may worsen over time [
         <a href="#rid50">
          50,51
         </a>
         ], but can also remain stable [
         <a href="#rid52">
          52
         </a>
         ], improve [
         <a href="#rid53">
          53,54
         </a>
         ], or even normalize [
         <a href="#rid55">
          55
         </a>
         ] if the bronchiectasis is diagnosed early and optimally treated.
        </p>
        <p>
         Other pulmonary function tests may be useful for selected patients (eg, if an asthmatic component of symptoms is suspected but cannot be established with office spirometry). (See
         <a class="local">
          'Special pulmonary function tests'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2378953914">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchiectasis is suspected in a child with chronic respiratory symptoms (especially chronic wet cough) or signs of severe respiratory disease (digital clubbing or hemoptysis) that are not otherwise explained  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ). It is more likely in children with risk factors for bronchiectasis, including established or suspected immunodeficiency or history of recurrent pneumonias or protracted bacterial bronchitis (PBB), and in children from a population with high rates of recurrent respiratory infection. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
         The diagnosis of bronchiectasis is established by the finding of abnormally dilated bronchi on imaging, typically high-resolution computed tomography (HRCT) with or without multidetector CT (MDCT). (See
         <a class="local">
          'Imaging'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3820979094">
         <span class="h1">
          FURTHER EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Laboratory studies for all patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to the imaging tests and spirometry described above, all patients with bronchiectasis should have the following basic panel of tests to screen for an underlying cause, as recommended in consensus guidelines [
         <a href="#rid8">
          8,38
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sweat chloride test – This should be performed for all children because neonatal screening can miss the diagnosis of cystic fibrosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count and immunologic tests (total immunoglobulin G, A, M, and E [IgG, IgA, IgM, IgE] specific antibodies to vaccine antigens) – This panel serves as an initial screen for some relatively common primary immunodeficiency disorders, such as common variable immunodeficiency and hyper-IgE syndrome.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lower airway bacteriology – Bacterial cultures are needed to guide a targeted antibiotic regimen [
         <a href="#rid8">
          8,38
         </a>
         ]. Sputum is the preferred lower airway specimen but may be difficult to obtain from young children, even when induced with normal or hypertonic
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         nebulization. Oropharyngeal and nasopharyngeal swab samples have been suggested as an alternative, but results from these specimens may not accurately predict lower airway bacteriology [
         <a href="#rid56">
          56
         </a>
         ]. Therefore, bronchoalveolar lavage may be required to obtain an accurate lower airway specimen in some patients. For bronchioalveolar lavage specimens, a diagnostic threshold of ≥10⁴ colony-forming units/mL of microorganism is typically used to define a clinically relevant infection in children with bronchiectasis [
         <a href="#rid57">
          57
         </a>
         ], based on limited data.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2900318927">
         <span class="h2">
          Other tests for selected patients
         </span>
        </p>
        <p class="headingAnchor" id="H2831079098">
         <span class="h3">
          Tests to determine the cause
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other tests may be needed to determine the cause of the bronchiectasis and are selected based on the child's clinical presentation  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid8">
          8
         </a>
         ]. The etiologies vary among cohorts depending on risk factors. As an example, a rare immunodeficiency may be more likely in a population with consanguinity or founder mutations, but the evaluation requires in-depth immune and/or genetic testing [
         <a href="#rid58">
          58
         </a>
         ] that may not be available in some settings.
        </p>
        <p>
         Examples of targeted evaluations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In-depth immunologic assessments for children with evidence of immunodeficiency (in consultation with a pediatric immunologist) (see
         <a class="medical medical_review" href="/z/d/html/5949.html" rel="external">
          "Approach to the child with recurrent infections"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diagnostic bronchoscopy to assess for large airway obstruction with bronchoalveolar lavage for microbiology in children with focal findings on imaging or suspected foreign body aspiration and/or if lower airway specimens are needed for bacteriology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tests for swallowing dysfunction and aspiration in children with risk factors such as neurologic impairment or feeding problems (see
         <a class="medical medical_review" href="/z/d/html/14537.html" rel="external">
          "Aspiration due to swallowing dysfunction in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Testing for primary ciliary dyskinesia in a child with neonatal respiratory distress, recurrent upper and lower respiratory infections, and/or situs inversus (see
         <a class="medical medical_review" href="/z/d/html/4338.html" rel="external">
          "Primary ciliary dyskinesia (immotile-cilia syndrome)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evaluation for gastroesophageal disease in children with frequent regurgitation or heartburn (see
         <a class="medical medical_review" href="/z/d/html/5892.html" rel="external">
          "Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genetics assessment for children with congenital anomalies or syndromic features or a known or suspected genetic disorder (refer to appropriate topic reviews)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tuberculosis testing or HIV screening in selected settings (eg, where tuberculosis or HIV have a high prevalence and/or there is a history of close contact with tuberculosis) (see
         <a class="medical medical_review" href="/z/d/html/8007.html" rel="external">
          "Tuberculosis disease in children: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5962.html" rel="external">
          "Epidemiology of pediatric HIV infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">
          "Screening and diagnostic testing for HIV infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3288075201">
         <span class="h3">
          Special pulmonary function tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of specialized pulmonary function tests are available, although the more complex tests (eg, static lung volumes, lung clearance index, forced oscillatory test) are only available in specialist hospitals and/or research units.
        </p>
        <p>
         Some patients with bronchiectasis have an asthma phenotype that coexists or complicates the clinical management [
         <a href="#rid24">
          24
         </a>
         ]. In many cases, the asthma can be demonstrated by standard spirometry (ie, an obstructive pattern that reverses with bronchodilatory administration). In selected cases in which spirometry is unclear, an airway hyperresponsiveness or bronchoprovocation test (eg,
         <a class="drug drug_pediatric" data-topicid="12570" href="/z/d/drug information/12570.html" rel="external">
          mannitol
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="126558" href="/z/d/drug information/126558.html" rel="external">
          methacholine
         </a>
         challenge) may be useful. While lower airway eosinophilia is found in some children with bronchiectasis [
         <a href="#rid59">
          59
         </a>
         ], the utility of fractional exhaled nitric oxide (FeNO; a biomarker for lower airway eosinophilia) has not yet been examined in children with bronchiectasis. Details on the evaluation and diagnosis of asthma are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5735.html" rel="external">
          "Overview of pulmonary function testing in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5742.html" rel="external">
          "Asthma in children younger than 12 years: Initial evaluation and diagnosis"
         </a>
         .)
        </p>
        <p>
         Measures of static lung volume and diffusion capacity (specialized pulmonary function tests used in pulmonology clinics) have not been well studied in children with bronchiectasis. Static lung volume (and, specifically, increased residual volume) is more closely correlated with radiographic assessment of bronchiectasis severity than it is with spirometry, based on data from children with primary ciliary dyskinesia [
         <a href="#rid60">
          60
         </a>
         ]. In adults with bronchiectasis, reduced total lung capacity and diffusion capacity are associated with increased mortality [
         <a href="#rid61">
          61
         </a>
         ]. Reduced exercise capacity (on cycle ergometry and aerobic capacity) has been described in children with bronchiectasis but does not correlate with severity of bronchiectasis, based on HRCT scores [
         <a href="#rid47">
          47,62
         </a>
         ].
        </p>
        <p>
         In research, lung clearance index is used as an outcome measure in some studies of children with cystic fibrosis but appears to be less useful in other populations with bronchiectasis [
         <a href="#rid63">
          63
         </a>
         ]. Further, this test is not feasible for routine clinical practice, because it requires specialized equipment, technical expertise, and time.
        </p>
        <p class="headingAnchor" id="H2549325485">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/116208.html" rel="external">
          "Society guideline links: Bronchiectasis"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118986.html" rel="external">
          "Society guideline links: Hemoptysis"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/122199.html" rel="external">
          "Society guideline links: Primary ciliary dyskinesia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H81825312">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/16905.html" rel="external">
          "Patient education: Coughing up blood (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/86714.html" rel="external">
          "Patient education: Bronchiectasis in children (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and causes
         </strong>
         – Bronchiectasis in children is defined as the presence of abnormal bronchial dilatation on chest computed tomography (CT) scans in combination with a clinical syndrome of recurrent or persistent wet/productive cough, airway infection, and/or inflammation. It is the end result of a variety of illnesses, including congenital malformations, cystic fibrosis, primary immunodeficiencies, retained airway foreign body, or postinfectious processes  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Definition'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6358.html" rel="external">
          "Bronchiectasis in children: Pathophysiology and causes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Children and youth with bronchiectasis can present with a variety of nonspecific symptoms and signs, the most common of which is a chronic cough that sounds wet and/or is productive of mucus  (
         <a class="graphic graphic_table graphicRef131075" href="/z/d/graphic/131075.html" rel="external">
          table 1
         </a>
         ). Those with advanced disease may develop dyspnea, hemoptysis, and/or digital clubbing. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and diagnosis
         </strong>
         – The initial evaluation for a child with suspected bronchiectasis includes a focused medical history and physical examination; chest radiograph; high-resolution CT (HRCT), ideally with multidetector CT (MDCT); and spirometry. (See
         <a class="local">
          'Initial evaluation of suspected bronchiectasis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Imaging
         </strong>
         – The diagnosis of bronchiectasis is confirmed if HRCT demonstrates abnormally dilated bronchi  (
         <a class="graphic graphic_diagnosticimage graphicRef131113" href="/z/d/graphic/131113.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef131112" href="/z/d/graphic/131112.html" rel="external">
          image 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef131114" href="/z/d/graphic/131114.html" rel="external">
          image 4
         </a>
         ). (See
         <a class="local">
          'Imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Spirometry
         </strong>
         – Spirometry should be performed at diagnosis and with serial measures in follow-up. The typical spirometric abnormality in bronchiectasis is an obstructive pattern where the forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) is low, with preserved forced vital capacity (FVC)  (
         <a class="graphic graphic_figure graphicRef131119" href="/z/d/graphic/131119.html" rel="external">
          figure 3
         </a>
         ). Spirometry can be normal in mild disease  (
         <a class="graphic graphic_figure graphicRef131118" href="/z/d/graphic/131118.html" rel="external">
          figure 5
         </a>
         ) or can show a restrictive pattern. (See
         <a class="local">
          'Spirometry'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory testing
         </strong>
         – In addition to the imaging tests and spirometry, all patients with bronchiectasis should have a basic panel of tests, including sweat chloride, complete blood count and immunologic tests (total immunoglobulin G, A, M, and E [IgG, IgA, IgM, IgE], specific antibodies to vaccine antigens), and lower airway bacteriology (on sputum or sample from bronchoalveolar lavage). These tests screen for an underlying cause and guide antibiotic therapy. Other tests may be needed to determine the cause of the bronchiectasis and are selected based on the child's clinical presentation  (
         <a class="graphic graphic_table graphicRef87712" href="/z/d/graphic/87712.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef71732" href="/z/d/graphic/71732.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Further evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H737608747">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Khoulood Fakhoury, MD, and Adaobi Kanu, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Redding GJ, Singleton RJ, Valery PC, et al. Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Chest 2014; 146:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 2016; 47:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nathan AM, Muthusamy A, Thavagnanam S, et al. Chronic suppurative lung disease in a developing country: impact on child and parent. Pediatr Pulmonol 2014; 49:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome. Indian Pediatr 2015; 52:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet 2018; 392:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal V, McPhail SM, Hurley F, et al. Cost of hospitalization for bronchiectasis exacerbation in children. Respirology 2020; 25:1250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Primers 2018; 4:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Fortescue R, Grimwood K, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J 2021; 58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCallum GB, Binks MJ. The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents. Front Pediatr 2017; 5:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singleton RJ, Valery PC, Morris P, et al. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol 2014; 49:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahçeci S, Karaman S, Nacaroğlu HT, et al. Changing epidemiology of non-cystic fibrosis bronchiectasis. Turk J Pediatr 2016; 58:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur N, Karadag B. Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries. Paediatr Respir Rev 2011; 12:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Van Asperen PP, Glasgow N, et al. Children with chronic cough: when is watchful waiting appropriate? development of likelihood ratios for assessing children with chronic cough. Chest 2015; 147:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards EA, Metcalfe R, Milne DG, et al. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr Pulmonol 2003; 36:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal V, Grimwood K, Marchant J, et al. Pediatric bronchiectasis: No longer an orphan disease. Pediatr Pulmonol 2016; 51:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur N, Masters IB, Morris PS, et al. Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol 2012; 47:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal V, Grimwood K, Marchant J, et al. Does failed chronic wet cough response to antibiotics predict bronchiectasis? Arch Dis Child 2014; 99:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patria MF, Longhi B, Lelii M, et al. Children with recurrent pneumonia and non-cystic fibrosis bronchiectasis. Ital J Pediatr 2016; 42:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HY, Kwon JW, Seo J, et al. Bronchiectasis in children: 10-year experience at a single institution. Allergy Asthma Immunol Res 2011; 3:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wurzel DF, Marchant JM, Yerkovich ST, et al. Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis. Chest 2016; 150:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruffles TJC, Marchant JM, Masters IB, et al. Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study. Respirology 2021; 26:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCallum GB, Chatfield MD, Morris PS, Chang AB. Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis. Pediatr Pulmonol 2016; 51:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal V, Grimwood K, Ware RS, et al. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial. Lancet Respir Med 2019; 7:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koh YY, Lee MH, Sun YH, et al. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J 1997; 10:994.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moynihan KM, Ge S, Sleeper LA, et al. Life-Threatening Hemoptysis in a Pediatric Referral Center. Crit Care Med 2021; 49:e291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Satırer O, Mete Yesil A, Emiralioglu N, et al. A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience. Respir Med 2018; 137:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nathan AM, de Bruyne JA, Eg KP, Thavagnanam S. Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis. Front Pediatr 2017; 5:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahali K, Gedik AH, Bilgic A, et al. The relationship between psychological symptoms, lung function and quality of life in children and adolescents with non-cystic fibrosis bronchiectasis. Gen Hosp Psychiatry 2014; 36:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirra V, Maglione M, Di Micco LL, et al. Longitudinal Follow-up of Chronic Pulmonary Manifestations in Esophageal Atresia: A Clinical Algorithm and Review of the Literature. Pediatr Neonatol 2017; 58:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Malki TA. Lung resections in bronchiectasis due to lipoid pneumonia: a custom-design approach. East Afr Med J 2000; 77:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marangu D, Gray D, Vanker A, Zampoli M. Exogenous lipoid pneumonia in children: A systematic review. Paediatr Respir Rev 2020; 33:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joschtel B, Gomersall SR, Tweedy S, et al. Objectively measured physical activity and sedentary behaviour in children with bronchiectasis: a cross-sectional study. BMC Pulm Med 2019; 19:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Oppenheimer JJ, Irwin RS, CHEST Expert Cough Panel. Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest 2020; 158:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGuinness G, Naidich DP, Leitman BS, McCauley DI. Bronchiectasis: CT evaluation. AJR Am J Roentgenol 1993; 160:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverman PM, Godwin JD. CT/bronchographic correlations in bronchiectasis. J Comput Assist Tomogr 1987; 11:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossi UG, Owens CM. The radiology of chronic lung disease in children. Arch Dis Child 2005; 90:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brody A, Chang A. The imaging definition of bronchiectasis in children: Is it time for a change? Pediatr Pulmonol 2018; 53:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Bell SC, Torzillo PJ, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust 2015; 202:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill LE, Ritchie G, Wightman AJ, et al. Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis. Br J Radiol 2010; 83:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodd JD, Souza CA, Müller NL. Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis. AJR Am J Roentgenol 2006; 187:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serra G, Milito C, Mitrevski M, et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011; 140:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GUDBJERG CE. Roentgenologic diagnosis of bronchiectasis; an analysis of 112 cases. Acta radiol 1955; 43:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991; 179:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiff DB, Wells AU, Carr DH, et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol 1995; 165:261.
          </a>
         </li>
         <li class="breakAll">
          Webb WR, Muller NL, Naidich DP. High-resolution computed tomography findings of lung disease. In: High-Resolution CT of the Lung, 3rd ed, Lippincott Williams &amp; Wilkins, 2001. p.71.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang AB, Masel JP, Boyce NC, et al. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol 2003; 35:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards EA, Narang I, Li A, et al. HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis. Eur Respir J 2004; 24:538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchant JM, Masel JP, Dickinson FL, et al. Application of chest high-resolution computer tomography in young children with cystic fibrosis. Pediatr Pulmonol 2001; 31:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santamaria F, Montella S, Camera L, et al. Lung structure abnormalities, but normal lung function in pediatric bronchiectasis. Chest 2006; 130:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Twiss J, Stewart AW, Byrnes CA. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis. Thorax 2006; 61:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munro KA, Reed PW, Joyce H, et al. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pulmonol 2011; 46:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCallum GB, Singleton RJ, Redding GJ, et al. A decade on: Follow-up findings of indigenous children with bronchiectasis. Pediatr Pulmonol 2020; 55:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability? Chest 2010; 138:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bastardo CM, Sonnappa S, Stanojevic S, et al. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function. Thorax 2009; 64:246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collaro AJ, Chang AB, Marchant JM, et al. Pediatric Patients of Outreach Specialist Queensland Clinics Have Lung Function Improvement Comparable to That of Tertiary Pediatric Patients. Chest 2020; 158:1566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hare KM, Chang AB, Smith-Vaughan HC, et al. Do combined upper airway cultures identify lower airway infections in children with chronic cough? Pediatr Pulmonol 2019; 54:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hare KM, Pizzutto SJ, Chang AB, et al. Defining lower airway bacterial infection in children with chronic endobronchial disorders. Pediatr Pulmonol 2018; 53:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marciano BE, Holland SM. Primary Immunodeficiency Diseases: Current and Emerging Therapeutics. Front Immunol 2017; 8:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizzutto SJ, Grimwood K, Bauert P, et al. Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis. Pediatr Pulmonol 2013; 48:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pifferi M, Bush A, Pioggia G, et al. Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia. Thorax 2012; 67:993.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loebinger MR, Wells AU, Hansell DM, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009; 34:843.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swaminathan S, Kuppurao KV, Somu N, Vijayan VK. Reduced exercise capacity in non-cystic fibrosis bronchiectasis. Indian J Pediatr 2003; 70:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grillo L, Irving S, Hansell DM, et al. The reproducibility and responsiveness of the lung clearance index in bronchiectasis. Eur Respir J 2015; 46:1645.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6360 Version 24.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24811693" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26541539" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24482322" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Chronic suppurative lung disease in a developing country: impact on child and parent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25638182" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30215382" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Bronchiectasis in children: diagnosis and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32358912" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Cost of hospitalization for bronchiectasis exacerbation in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30442957" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33542057" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28265556" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23401398" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27922232" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Changing epidemiology of non-cystic fibrosis bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21458736" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25501672" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Children with chronic cough: when is watchful waiting appropriate? development of likelihood ratios for assessing children with chronic cough.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12833486" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26840008" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Pediatric bronchiectasis: No longer an orphan disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21830316" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24521788" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Does failed chronic wet cough response to antibiotics predict bronchiectasis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26861259" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Children with recurrent pneumonia and non-cystic fibrosis bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21217924" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Bronchiectasis in children: 10-year experience at a single institution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27400908" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33045125" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26575201" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31427252" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9163637" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33405412" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Life-Threatening Hemoptysis in a Pediatric Referral Center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29605210" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28596950" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25011602" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The relationship between psychological symptoms, lung function and quality of life in children and adolescents with non-cystic fibrosis bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27328637" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Longitudinal Follow-up of Chronic Pulmonary Manifestations in Esophageal Atresia: A Clinical Algorithm and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12858904" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Lung resections in bronchiectasis due to lipoid pneumonia: a custom-design approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30962152" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Exogenous lipoid pneumonia in children: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30621677" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Objectively measured physical activity and sedentary behaviour in children with bronchiectasis: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32179109" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8424327" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Bronchiectasis: CT evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3805429" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : CT/bronchographic correlations in bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15908625" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The radiology of chronic lung disease in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29136339" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The imaging definition of bronchiectasis in children: Is it time for a change?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25588439" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19505963" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Comparison between conventional interrupted high-resolution CT and volume multidetector CT acquisition in the assessment of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16861546" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Conventional high-resolution CT versus helical high-resolution MDCT in the detection of bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21622550" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14376133" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Roentgenologic diagnosis of bronchiectasis; an analysis of 112 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2027992" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Cystic fibrosis: scoring system with thin-section CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7618537" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7618537" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12746947" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Non-CF bronchiectasis: clinical and HRCT evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15459130" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11180671" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Application of chest high-resolution computer tomography in young children with cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16899848" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Lung structure abnormalities, but normal lung function in pediatric bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16467074" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20717910" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32096916" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A decade on: Follow-up findings of indigenous children with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20173055" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19052050" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32387516" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Pediatric Patients of Outreach Specialist Queensland Clinics Have Lung Function Improvement Comparable to That of Tertiary Pediatric Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31006971" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Do combined upper airway cultures identify lower airway infections in children with chronic cough?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29265639" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Defining lower airway bacterial infection in children with chronic endobronchial disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28848545" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Primary Immunodeficiency Diseases: Current and Emerging Therapeutics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22431241" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22771515" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19357155" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Mortality in bronchiectasis: a long-term study assessing the factors influencing survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12940377" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Reduced exercise capacity in non-cystic fibrosis bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26341989" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : The reproducibility and responsiveness of the lung clearance index in bronchiectasis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
